The new facility will be used for primary and secondary packaging, labeling, distribution and warehouse services.
The facility will also be audited and approved for domestic as well as European clinical trials, according to Xcelience.
Xcelience CEO and president Derek Hennecke said the company works on several dozens of molecules, each of which has the potential to improve people’s lives.
"We love being in Tampa, because through USF, UF and Tampa’s growing biotech community, we have access to scientists at the height of their field," Hennecke added.
Tampa Mayor Bob Buckhorn said Tampa’s health sciences cluster is creating the jobs of the future.
"I am proud Xcelience calls Tampa home, and congratulate them on the opening of their second facility here," Buckhorn added.
The new plant is expected to enable Xcelience to double its employment again over the next three years.